GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (OTCPK:SBLOF) » Definitions » 12-1 Month Momentum %

Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) 12-1 Month Momentum % : N/A% (As of Jun. 08, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Shin Nippon Biomedical Laboratories 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-08), Shin Nippon Biomedical Laboratories's 12-1 Month Momentum % is N/A%.

The industry rank for Shin Nippon Biomedical Laboratories's 12-1 Month Momentum % or its related term are showing as below:

SBLOF's 12-1 Month Momentum % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -17.025
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Shin Nippon Biomedical Laboratories's 12-1 Month Momentum %

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's 12-1 Month Momentum % falls into.



Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Shin Nippon Biomedical Laboratories 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (Shin Nippon Biomedical Laboratories) Headlines

From GuruFocus

Advantech Connect: Co-Creating The Future of The IoT World

By Business Wire Business Wire 02-16-2021

Advantech Introduces New AIM-75S Industrial Tablet

By Business Wire Business Wire 04-29-2021

ADVA and Advantech Open Remote Lab to Streamline uCPE Adoption

By Business Wire Business Wire 12-09-2020

Advantech Opens New Offices in United States/Canada

By Business Wire Business Wire 10-15-2020

Advantech Year-in-Review: 2020 Highlights

By Business Wire Business Wire 12-15-2020